mounjaro eli lilly news - Search News

Food and Drug Administration, Lilly

Barron's on MSN · 13h

Eli Lilly’s Weight-Loss Drugs No Longer In Shortage. It’s Bad News for These Stocks.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

The Wall Street Journal on MSN · 2h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

USA Today · 5h

Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.

10h

Mounjaro and Zepbound Are No Longer in Shortage, F.D.A. Says

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

NHS England proposes phased rollout for Eli Lilly's star obesity drug

While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...

Zacks.com on MSN6h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results